Historic CRISPR drug approval heralds new era in Cas9 IP wars
Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.
Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.
Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals
The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023
Life sciences companies are among those leading the way in going to court to get the current rules struck down
20 August 2021
Life sciences innovators may be compelled to hand over trade secrets, data and biological materials under legislation that now only requires President Bolsonaro’s signature to become law
19 August 2021
Boom in digital healthcare and bioinformatics IP requires strategic adjustments in both the life sciences and high-tech arenas
17 August 2021
$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field
12 August 2021
There are a lot of potential benefits to the new system, but we need to integrate it into our strategies to make sure it works, explains Joerg Thomaier
11 August 2021
The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams
05 August 2021
The Virginia-based R&D outfit has made a string of sales to big names in consumer tech over recent months, with Samsung another prominent customer
26 July 2021
Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement
07 July 2021
In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court.
01 July 2021
Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP
29 June 2021
Unlock unlimited access to all IAM content